☆ 4.6 Article

Fibroblast Growth Factor 21 in Chronic Hepatitis C: A Potential Non-Invasive Biomarker of Liver Status upon Viral Eradication

METABOLITES (2023)

Related references

Note: Only part of the references are listed.

Editorial Material Endocrinology & Metabolism

Editorial: The liver as an endocrine organ: Hepatokines and ketone bodies, novel hormones to be acknowledged

Renata Risi et al.

FRONTIERS IN ENDOCRINOLOGY (2023)

Add to Collection

Article Nutrition & Dietetics

Predictors of weight loss in patients with obesity treated with a Very Low-Calorie Ketogenic Diet

Ilaria Ernesti et al.

Summary: The Very Low-Calorie Ketogenic Diet (VLCKD) is a safe and effective intervention for metabolic diseases and obesity. This study examined the predictors of weight loss during VLCKD treatment, including the role of Fibroblast Growth Factor 21 (FGF21). Results revealed that VLCKD led to improvements in body weight, composition, and metabolic parameters. Lower baseline FGF21, male sex, and central obesity were associated with greater weight loss. This suggests that individuals with these characteristics may benefit more from VLCKD in terms of weight loss. More research is needed to determine if these findings are specific to VLCKD or apply to other calorie restriction diets.

FRONTIERS IN NUTRITION (2023)

Add to Collection

Article Cardiac & Cardiovascular Systems

Fibroblast growth factor 21 in heart failure

William Tucker et al.

Summary: Fibroblast growth factor 21 (FGF21) is a hormone involved in energy regulation and has been shown to protect against obesity and diabetes. However, its role in heart failure (HF) is not well understood. HF is a global health problem with a rising prevalence, especially in aging populations. The emergence of cardiac biomarkers has been of great interest in improving prediction, diagnosis, and prognosis of HF. Recent studies suggest that FGF21 may be a promising biomarker for HF, but there are conflicting findings in clinical literature. Further research is needed to understand the causal role of FGF21 in HF and its potential as a biomarker for prediction, diagnosis, and prognosis.

HEART FAILURE REVIEWS (2023)

Add to Collection

Review Gastroenterology & Hepatology

Global epidemiology of cirrhosis - aetiology, trends and predictions

Daniel Q. Huang et al.

Summary: Cirrhosis is a major cause of morbidity and mortality in people with chronic liver disease globally. The epidemiology and burden of cirrhosis are changing due to factors such as obesity, alcohol consumption, and improved management of viral hepatitis. This review highlights global trends in cirrhosis epidemiology, the contributions of various liver diseases, and suggests ways to tackle the increasing burden of cirrhosis.

NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2023)

Add to Collection

Article Endocrinology & Metabolism

The Effect of HCV Eradication after Direct-Acting Antiviral Agents on He-patic Steatosis: A Prospective Observational Study

Hanan Soliman et al.

Summary: This study assessed the prevalence of hepatic steatosis among HCV Egyptian patients and the long term changes occurring after viral eradication. The results showed that hepatic steatosis increased after successful DAAs treatment. BMI and CAP values were negatively correlated with hepatic fibrosis regression and positively correlated with steatosis progression. Therefore, HCV patients with hepatic steatosis may need close follow up.

ENDOCRINE METABOLIC & IMMUNE DISORDERS-DRUG TARGETS (2022)

Add to Collection

Article Gastroenterology & Hepatology

Global change in hepatitis C virus prevalence and cascade of care between 2015 and 2020: a modelling study

Sarah Blach et al.

Summary: This study aims to evaluate the burden of hepatitis C virus (HCV) in 2020 and forecast the burden by 2030. Using literature review, Delphi process, and mathematical modelling, it estimated the global prevalence of viraemic HCV infection to be 0.7% in 2020, corresponding to 56.8 million infections. The findings suggest that the current efforts are not on track to achieve the global elimination targets by 2030.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2022)

Add to Collection

Article Biology

PPAR Ligands Induce Antiviral Effects Targeting Perturbed Lipid Metabolism during SARS-CoV-2, HCV, and HCMV Infection

Marialuigia Fantacuzzi et al.

Summary: The current COVID-19 pandemic has led to increased research efforts in developing novel strategies to combat viral infections. Viral infections have been shown to significantly impact host metabolism, with studies focusing on these metabolic changes and suggesting new strategies to counteract the perturbed metabolism. This review focuses on PPARs, nuclear receptors that regulate multiple metabolic actions, and the effects of PPAR ligands during viral infections.

BIOLOGY-BASEL (2022)

Add to Collection

Article Endocrinology & Metabolism

An extra virgin olive oil-enriched chocolate spread positively modulates insulin-resistance markers compared with a palm oil-enriched one in healthy young adults: A double-blind, cross-over, randomised controlled trial

Dario Tuccinardi et al.

Summary: Partially replacing SFAs with MUFAs in a chocolate-based snack as part of a short-term isocaloric diet in healthy individuals may limit SFAs detrimental effects on insulin sensitivity and decrease circulating harmful sphingolipids in young adults.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2022)

Add to Collection

Article Multidisciplinary Sciences

Improvement of liver fibrosis, but not steatosis, after HCV eradication as assessment by MR-based imaging: Role of metabolic derangement and host genetic variants

Natthaya Chuaypen et al.

Summary: This study aimed to evaluate the continuous changes in fibrosis and steatosis in patients with HCV genotype 1 who achieved SVR. The study found that HCV eradication was associated with fibrosis improvement, but progressive steatosis was observed in a proportion of patients. By integrating genetic variations and clinical parameters, a better individualized strategy can be selected to alleviate progressive steatosis after HCV cure.

PLOS ONE (2022)

Add to Collection

Article Multidisciplinary Sciences

Associations between serum mitokine levels and outcomes in stable COPD: an observational prospective study

Carlos A. Amado et al.

Summary: Mitokines (Humanin (HN), GDF15, and FGF21) are produced due to mitochondrial dysfunction and play important roles in chronic inflammation, malnutrition, and exercise capacity in COPD patients. This study found that levels of HN and GDF-15 were higher in COPD patients compared to smokers without COPD. Higher levels of HN were associated with increased risk of exacerbation, malnutrition, decreased exercise capacity, and future moderate and severe exacerbations. Higher levels of GDF15 were associated with increased risk of exacerbation, decreased exercise capacity, and predicted desaturation in the 6-minute walk test (6MWT). Higher levels of FGF21 were associated with increased risk of exacerbation and predicted future severe exacerbations.

SCIENTIFIC REPORTS (2022)

Add to Collection

Article Endocrinology & Metabolism

FGF21 and Chronic Kidney Disease

Joao Victor Salgado et al.

Summary: The global nephrology community acknowledges the increasing burden of kidney disease and emphasizes on early diagnosis, understanding of disease progression, and development of new therapeutic interventions. FGF21 is considered a key regulator of lipid, glucose, and energy metabolism, as well as stress responses. While promising results have been shown with FGF21 analogs in metabolic disease, its exact role in kidney function remains poorly understood.

METABOLISM-CLINICAL AND EXPERIMENTAL (2021)

Add to Collection

Review Gastroenterology & Hepatology

Metabolic complications of hepatitis C virus infection

Rahul Chaudhari et al.

Summary: HCV infection is associated with extrahepatic organ dysfunction, such as atherosclerosis, metabolic disturbances, and lymphoproliferative diseases, in addition to liver manifestations. The close relationship between chronic HCV infection, metabolic disease, and cardiovascular disorders has significant implications for global health.

WORLD JOURNAL OF GASTROENTEROLOGY (2021)

Add to Collection

Article Biochemistry & Molecular Biology

FGF21 ameliorates hepatic fibrosis by multiple mechanisms

Fanrui Meng et al.

Summary: The study found that FGF21 improves hepatic fibrosis through regulating the leptin-STAT3 axis pathway, as well as the Nrf-2 and SOCS3 pathways in activated hepatic stellate cells.

MOLECULAR BIOLOGY REPORTS (2021)

Add to Collection

Article Gastroenterology & Hepatology

Hepatitis C Guidance 2019 Update: American Association for the Study of Liver Diseases-Infectious Diseases Society of America Recommendations for Testing, Managing, and Treating Hepatitis C Virus Infection

HEPATOLOGY (2020)

Add to Collection

Article Gastroenterology & Hepatology

The global, regional, and national burden of cirrhosis by cause in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

Sadaf G. Sepanlou et al.

LANCET GASTROENTEROLOGY & HEPATOLOGY (2020)

Add to Collection

Article Nutrition & Dietetics

Baseline HOMA IR and Circulating FGF21 Levels Predict NAFLD Improvement in Patients Undergoing a Low Carbohydrate Dietary Intervention for Weight Loss: A Prospective Observational Pilot Study

Mikiko Watanabe et al.

NUTRIENTS (2020)

Add to Collection

Article Multidisciplinary Sciences

Causes and trends in liver disease and hepatocellular carcinoma among men and women who received liver transplants in the US, 2010-2019

Sonia Wang et al.

PLOS ONE (2020)

Add to Collection

Article Endocrinology & Metabolism

Liver-derived FGF21 is essential for full adaptation to ketogenic diet but does not regulate glucose homeostasis

Mikiko Watanabe et al.

ENDOCRINE (2020)

Add to Collection

Review Gastroenterology & Hepatology

Evolution and Revolution of Hepatitis C Management: From Non-A, Non-B Hepatitis Toward Global Elimination

Viktorija Basyte-Bacevice et al.

DIGESTIVE DISEASES (2020)

Add to Collection

Article Gastroenterology & Hepatology

Approaches, Progress, and Challenges to Hepatitis C Vaccine Development

Justin R. Bailey et al.

GASTROENTEROLOGY (2019)

Add to Collection

Review Endocrinology & Metabolism

Fibroblast growth factor 21 in non-alcoholic fatty liver disease

Bradley Tucker et al.

METABOLISM-CLINICAL AND EXPERIMENTAL (2019)

Add to Collection

Article Gastroenterology & Hepatology

Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy

T. Tada et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)

Add to Collection

Article Gastroenterology & Hepatology

EASL Recommendations on Treatment of Hepatitis C 2018

JOURNAL OF HEPATOLOGY (2018)

Add to Collection

Article Gastroenterology & Hepatology

Fibroblast growth factor 21 is an early predictor of acute-on-chronic liver failure in critically ill patients with cirrhosis

Astrid Ruiz-Margain et al.

LIVER TRANSPLANTATION (2018)

Add to Collection

Article Gastroenterology & Hepatology

A study of the circulating fibroblast growth factor 21 as a novel noninvasive biomarker of hepatic injury in genotype-4 chronic hepatitis C: Egyptian patients and their response to direct-acting antiviral agents

Ghada M. El Sagheer et al.

CLINICAL AND EXPERIMENTAL GASTROENTEROLOGY (2018)

Add to Collection

Review Gastroenterology & Hepatology

Hepatitis C Virus and Hepatocellular Carcinoma: A Narrative Review

Page Axley et al.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2018)

Add to Collection

Article Endocrinology & Metabolism

Fibroblast growth factor 21 (FGF21) is robustly induced by ethanol and has a protective role in ethanol associated liver injury

Bhavna N. Desai et al.

MOLECULAR METABOLISM (2017)

Add to Collection

Article Endocrinology & Metabolism

FGF21 resistance is not mediated by downregulation of beta-klotho expression in white adipose tissue

Kathleen R. Markan et al.

MOLECULAR METABOLISM (2017)

Add to Collection

Article Biochemistry & Molecular Biology

Fibroblast growth factor 21 and its novel association with oxidative stress

Miguel Angel Gomez-Samano et al.

REDOX BIOLOGY (2017)

Add to Collection

Review Cell Biology

Regulation of longevity by FGF21: Interaction between energy metabolism and stress responses

Antero Salminen et al.

AGEING RESEARCH REVIEWS (2017)

Add to Collection

Review Physiology

Understanding the Physiology of FGF21

Ffolliott Martin Fisher et al.

ANNUAL REVIEW OF PHYSIOLOGY, VOL 78 (2016)

Add to Collection

Review Cell Biology

HCV and Oxidative Stress: Implications for HCV Life Cycle and HCV-Associated Pathogenesis

Regina Medvedev et al.

OXIDATIVE MEDICINE AND CELLULAR LONGEVITY (2016)

Add to Collection

Article Multidisciplinary Sciences

Circulating Fibroblast Growth Factor 21 Is A Sensitive Biomarker for Severe Ischemia/reperfusion Injury in Patients with Liver Transplantation

Dewei Ye et al.

SCIENTIFIC REPORTS (2016)

Add to Collection

Article Gastroenterology & Hepatology

Expanded Classification of Hepatitis C Virus Into 7 Genotypes and 67 Subtypes: Updated Criteria and Genotype Assignment Web Resource

Donald B. Smith et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Fibroblast Growth Factor 21 Protects Against Acetaminophen-Induced Hepatotoxicity by Potentiating Peroxisome Proliferator-Activated Receptor Coactivator Protein-1α-Mediated Antioxidant Capacity in Mice

Dewei Ye et al.

HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Facts and fictions of HCV and comorbidities: Steatosis, diabetes mellitus, and cardiovascular diseases

Francesco Negro

JOURNAL OF HEPATOLOGY (2014)

Add to Collection

Article Gastroenterology & Hepatology

Activation of Liver FGF21 in hepatocarcinogenesis and during hepatic stress

Chaofeng Yang et al.

BMC GASTROENTEROLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

APRI, the FIB-4 score, and Forn's index have noninvasive diagnostic value for liver fibrosis in patients with chronic hepatitis B

Fatma Ucar et al.

EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY (2013)

Add to Collection

Article Gastroenterology & Hepatology

Serum FGF21 and RBP4 levels in patients with chronic hepatitis C

Michal Kukla et al.

SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2012)

Add to Collection

Article Gastroenterology & Hepatology

Alteration of Hepatic Nuclear Receptor-Mediated Signaling Pathways in Hepatitis C Virus Patients With and Without a History of Alcohol Drinking

Chuanghong Wu et al.

HEPATOLOGY (2011)

Add to Collection

Review Virology

A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation

Waqar Ahmad et al.

VIROLOGY JOURNAL (2011)

Add to Collection

Article Gastroenterology & Hepatology

Increased Fibroblast Growth Factor 21 in Obesity and Nonalcoholic Fatty Liver Disease

Jody Dushay et al.

GASTROENTEROLOGY (2010)

Add to Collection

Review Medicine, Research & Experimental

Peroxisome Proliferator-Activated Receptors in HCV-Related Infection

Sebastien Dharancy et al.

PPAR RESEARCH (2009)

Add to Collection

Article Gastroenterology & Hepatology

Peroxisome proliferator-activated receptor-alpha and -gamma rnRNA levels are reduced in chronic hepatitis C with steatosis and genotype 3 infection

A De Gottardi et al.

ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2006)

Add to Collection

Article Gastroenterology & Hepatology

Impaired expression of the peroxisome proliferator-activated receptor alpha during hepatitis C virus infection

S Dharancy et al.

GASTROENTEROLOGY (2005)

Add to Collection

© Peeref 2019-2024. All rights reserved.